Platelet Fcγ RIIA: An emerging regulator and biomarker in cardiovascular disease and cancer

被引：2
|
作者：
Zhang, Qingsong [1 ]
Li, Wenxian [1 ]
Mao, Xin [1 ]
Miao, Shuo [2 ]
机构：
[1] Qingdao Univ, Affiliated Hosp, Dept Urol, Qingdao, Peoples R China
[2] Qingdao Univ, Sch Basic Med, Qingdao, Peoples R China
来源：
THROMBOSIS RESEARCH | 2024年 / 238卷
关键词：
Platelet; Fc gamma RIIA; Cardiovascular disease; cancer; MONOCLONAL-ANTIBODIES; RECEPTOR EXPRESSION; IMMUNE-COMPLEXES; IMMUNOGLOBULIN-G; TRANSGENIC MICE; ACTIVATION; THROMBOSIS; COLLAGEN; BINDING; IDENTIFICATION;
D O I：
10.1016/j.thromres.2024.04.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Platelets, anucleate blood cells derive from megakaryocytes, are involved in cardiovascular diseases and tumors. Fc gamma RIIA, the only Fc gamma R expressed on human platelets, is known for its role in immune-related diseases. A growing body of evidence reveals that platelet Fc gamma RIIA is a potential target for the prevention and control of cardiovascular disease and cancer, and is an advantageous biomarker. In this review, we describe the structure and physiological function of platelet Fc gamma RIIA, its regulatory role in cardiovascular disease and cancer, and its potential clinical application.
引用
收藏
页码：19 / 26
页数：8
相关论文
共 50 条
  • [11] Assessment of Platelet Respiration as Emerging Biomarker of Disease
    Petrus, A. T.
    Lighezan, D. L.
    Danila, M. D.
    Duicu, O. M.
    Sturza, A.
    Muntean, D. M.
    Ionita, I.
    PHYSIOLOGICAL RESEARCH, 2019, 68 (03) : 347 - 363
  • [12] Platelet FcγRIIA receptor surface expression is increased in patients with ESRD and is associated with atherosclerotic cardiovascular events
    El-Shahawy, Mohamed
    Noureddin, Mazen
    Abdullah, Hesham
    Mack, Wendy J.
    Calverley, David C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (01) : 127 - 134
  • [13] Platelet FcγRIIa Expression in Ischemic Stroke: A Marker of Increased Platelet Reactivity
    Schneider, David J.
    Honda, Tristan
    Feldmann, Edward
    de Havenon, Adam
    Romano, Jose G.
    Nogueira, Raul G.
    Prabhakaran, Shyam
    Mishra, Nishant K.
    Beaman, Charles B.
    Hinman, Jason
    Commichau, Christopher S.
    Callas, Peter
    Kaneko, Naoki
    Morales, Jose M.
    Patel, Smit D.
    Sharma, Latisha K.
    Kim, Song Julia
    Taatjes-Sommer, Heidi S.
    Liebeskind, David S.
    STROKE-VASCULAR AND INTERVENTIONAL NEUROLOGY, 2022, 2 (03):
  • [14] FcγRIIa Ligation Induces Platelet Hypersensitivity to Thrombotic Stimuli
    Berlacher, Mark D.
    Vieth, Joshua A.
    Heflin, Brittany C.
    Gay, Steven R.
    Antczak, Adam J.
    Tasma, Brian E.
    Boardman, Holly J.
    Singh, Navinderjit
    Montel, Angela H.
    Kahaleh, M. Bashar
    Worth, Randall G.
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (01): : 244 - 254
  • [15] Variation in platelet expression of FcγRIIa after myocardial infarction
    Sean R. McMahon
    Sreedivya Chava
    Heidi S. Taatjes-Sommer
    Sean Meagher
    Kathleen E. Brummel-Ziedins
    David J. Schneider
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 88 - 94
  • [16] Cystatin C: An Emerging Biomarker in Cardiovascular Disease
    Angelidis, Christos
    Deftereos, Spyridon
    Giannopoulos, Georgios
    Anatoliotakis, Nikolaos
    Bouras, Georgios
    Hatzis, Georgios
    Panagopoulou, Vasiliki
    Pyrgakis, Vlasios
    Cleman, Michael W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (02) : 164 - 179
  • [17] Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcγRIIa
    Shuo Miao
    Dan Shu
    Ying Zhu
    Meng Lu
    Qingsong Zhang
    Youliang Pei
    Ao-Di He
    Rong Ma
    Bixiang Zhang
    Zhang-Yin Ming
    Cell Death & Disease, 10
  • [18] Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcγRIIa
    Miao, Shuo
    Shu, Dan
    Zhu, Ying
    Lu, Meng
    Zhang, Qingsong
    Pei, Youliang
    He, Ao-Di
    Ma, Rong
    Zhang, Bixiang
    Ming, Zhang-Yin
    CELL DEATH & DISEASE, 2019, 10 (2)
  • [19] Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation
    Yeung, Jennifer
    Tourdot, Benjamin E.
    Fernandez-Perez, Pilar
    Vesci, Joanne
    Ren, Jin
    Smyrniotis, Christopher J.
    Luci, Diane K.
    Jadhav, Ajit
    Simeonov, Anton
    Maloney, David J.
    Holman, Theodore R.
    McKenzie, Steven E.
    Holinstat, Michael
    BLOOD, 2014, 124 (14) : 2271 - 2279
  • [20] FcγRIIa and FcγRIIIa Polymorphisms and Cetuximab Benefit in the Microscopic Disease
    Sclafani, Francesco
    de Castro, David Gonzalez
    Cunningham, David
    Wilson, Sanna Hulkki
    Peckitt, Clare
    Capdevila, Jaume
    Glimelius, Bengt
    Keraenen, Susana Rosello
    Wotherspoon, Andrew
    Brown, Gina
    Tait, Diana
    Begum, Ruwaida
    Thomas, Janet
    Oates, Jacqueline
    Chau, Ian
    CLINICAL CANCER RESEARCH, 2014, 20 (17) : 4511 - 4519
12345